全球样本有效性测试市场 – 行业趋势和 2030 年预测

 样本有效性测试市场分析和规模

药物筛查市场的不断增长、工作场所药物检测的偏好不断增加、全球药物滥用案件的增加以及政府对打击药物滥用的投入不断增加，这些是可能在 2023-2030 年预测期内推动样本有效性测试市场增长的一些主要因素。另一方面，即时诊断样本有效性测试的引入将创造更多机会，从而导致预测期内样本有效性测试市场的增长。

Data Bridge Market Research 分析，标本有效性测试市场在 2022 年的规模为 46.5 亿美元，预计到 2030 年将达到 78.4 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 6.75%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

样本有效性测试市场范围和细分  

Market Definition

SVT is important in health care efforts because it measures patient adherence, morale, and dependability in consultation with clinicians. SVT is commonly treated by therapists, who use the results to make treatment decisions for their patients' medical problems, such as medication and illegal drug use. In the absence of SVT, the health care provider may miss the patient's urine sample deviation in an effort to deceive the provider.

Specimen Validity Testing Market Dynamics

Drivers

• Rising number of drug screening labs

The increased number of drug screening labs and diagnostic centres, combined with effective testing methods, are some critical factors expected to drive the market, resulting in the prevalence of high drugs worldwide. Furthermore, illegal drug use, such as marijuana, heroin, cocaine, hallucinogens, and other non-medical alcoholic fluids and psychotropic medications, is raising awareness about the global specimen validity testing market. The government is also taking steps to promote drug screening programmes in the workplace for the benefit of the people, which will drive revenue growth in the specimen validity testing market during the forecast period.

• Rising usage of SVT

Law enforcement agencies use SVT to protect criminals and suspects by detecting the presence and traces of illicit drugs. It assists law enforcement agencies in studying the behaviour and causes of a specific crime. The rise in illegal drug use is driving the global specimen validity testing market. Furthermore, stringent testing laws and government funding to combat drug addiction are expected to drive the specimen validity testing market globally during the forecast period.

Opportunities

• Rise in research and development operations

The key factors driving the growth of the global specimen validity testing market are strong economic growth, an increase in disposable income, an expansion in healthcare infrastructure, and a sudden increase in investment from market players to reduce drug misuse. Growing factors for the global specimen validity testing market include drug testing laboratories expanding their research and development operations. As the number of people misusing drugs grows, so the market also grows. A presumptive test is a non-conclusive test used in criminal investigations to screen for the presence of a substance in a human body.

Restraints/Challenges

• High cost of screening tests

The prevalence of various drug screening tests and market consolidation will likely impede the growth of the specimen validity testing market during the forecast period. The time-consuming regulatory approval process for rapid testing products will be the market's biggest and most pressing challenge.

This specimen validity testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the specimen validity testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Specimen Validity Testing Market

The ongoing stress and uncertainty of COVID-19 have increased demand for psychological services in the United States, but anxiety and depression aren't the only mental health issues people are dealing with. According to experts, the misuse of opioids and stimulants is also on the rise, and psychologists are well-positioned to assist. According to an American Medical Association report, more than 40 U.S. states saw increases in opioid-related mortality in December of 2020, with ongoing concerns for those with substance use disorders. As drug use increased, the pandemic accounted for significant testing in many regions.

Global Specimen Validity Testing Market Scope

The specimen validity testing market is segmented on the basis of product and service, type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Service

• Reagents
• Calibrators
• Controls
• Assay Kits
• Disposables
• Services

 Type

• Laboratory Testing
• Rapid/PoC Testing

 End User

• Workplaces
• Drug Screening Laboratories
• Criminal Justice and Law Enforcement Agencies
• Pain Management Centers
• Drug Rehabilitation Centers
• Other End Users

Specimen Validity Testing Market Regional Analysis/Insights

The specimen validity testing market is analysed and market size insights and trends are provided by country, product and service, type, and end user as referenced above.

样本有效性测试市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于严格的法律盛行以及非法药物消费量的增加，以及政府用于遏制药物滥用的资金水平激增，北美在标本有效性测试市场中占据主导地位。

由于医疗保健基础设施的发展以及人民可支配收入水平的提高，预计亚太地区将在 2023 年至 2030 年的预测期内实现最高增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

样本有效性测试市场还为您提供了每个国家/地区医疗保健资本设备支出增长、样本有效性测试市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对样本有效性测试市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。

竞争格局和样本有效性测试市场份额分析

样本有效性测试市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对样本有效性测试市场的关注有关。

标本有效性测试市场的一些主要参与者包括：

• 雅培（美国）
• 赛默飞世尔科技公司（美国）
• 清教徒医疗产品公司 (美国)
• BD（美国）
• 美国实验室控股公司（美国）
• Lucence Health Inc.（新加坡）
• Hardy Diagnostics（美国）
• BTNX（加拿大）
• Formlabs（美国）
• Medline Industries, Inc.（美国）
• VIRCELL SL（西班牙）
• HiMedia 实验室（印度）
• 泰坦生物科技（印度）
• McDermott Will & Emery (美国)
• 奇迹清洁科技有限公司 (中国)
• Starplex Scientific Inc.（加拿大）
• DiaSorin Molecular LLC（美国）

SKU-56898